PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
Clinical trial NCT06423144 · UNKNOWN
Trial details
- NCT number
- NCT06423144
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2024-08-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.